期刊
HYPERTENSION RESEARCH
卷 35, 期 11, 页码 1058-1062出版社
SPRINGERNATURE
DOI: 10.1038/hr.2012.96
关键词
amlodipine; antioxidative property; cilnidipine; renoprotective effect
资金
- Ministry of Education, Culture, Sports, Science and Technology of Japan (Knowledge Cluster and Scientific Research on Innovative Areas)
- Ministry of Health, Labor and Welfare of Japan
- Grants-in-Aid for Scientific Research [24659392, 22390159] Funding Source: KAKEN
Cilnidipine, an L/N-type calcium channel blocker (CCB), has been reported to have more beneficial effects on proteinuria progression in hypertensive patients than amlodipine, an L-type CCB. The N-type calcium channel blockade that inhibits renal sympathetic nerve activity might reduce glomerular hypertension by facilitating vasodilation of the efferent arterioles. However, the precise mechanism of the renoprotective effect of cilnidipine remains unknown. Because cilnidipine exerted significantly higher antioxidant activity than amlodipine in cultured human mesangial cells, we hypothesized that cilnidipine might exert a renoprotective effect by suppressing oxidative stress. A total of 35 hypertensive patients receiving a renin-angiotensin system inhibitor were randomly assigned to a cilnidipine (n = 18; 10 mg per day cilnidipine titrated to 20 mg per day) or amlodipine (n = 17; 5 mg per day amlodipine titrated to 10 mg per day) group; the target blood pressure (BP) was set at 130/85 mmHg. After 6 months of treatment, systolic and diastolic BPs were significantly reduced in both of the groups, without any significant difference between the groups. The urinary albumin, 8-hydroxy-2'-deoxyguanosine (OHdG) and liver-type fatty-acid-binding protein (L-FABP) to creatinine ratios significantly decreased in the cilnidipine group (P<0.05) compared with those in the amlodipine group. The reductions in urinary albumin, 8-OHdG and L-FABP were not correlated with the change in systolic BP. In conclusion, cilnidipine, but not amlodipine, ameliorated urinary albumin excretion and decreased urinary 8-OHdG and L-FABP in the hypertensive patients. Cilnidipine probably exerts a greater renoprotective effect through its antioxidative properties. Hypertension Research (2012) 35, 1058-1062; doi:10.1038/hr.2012.96; published online 5 July 2012
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据